VistaGen Therapeutics logo
VistaGen Therapeutics VTGN
$ 3.08 -0.32%

Quarterly report 2024-Q2
added 08-13-2024

report update icon

VistaGen Therapeutics Operating Cash Flow 2011-2024 | VTGN

Annual Operating Cash Flow VistaGen Therapeutics

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-25.8 M -49.7 M -45.3 M -12.1 M -15.8 M -14.5 M -9.06 M - - -2.77 M -2.13 M -3.46 M -3.57 M -841 K

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-841 K -49.7 M -15.4 M

Quarterly Operating Cash Flow VistaGen Therapeutics

2024-Q2 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-10.9 M - - -7.89 M - - -42.2 M -16 M - - -29.7 M -17.6 M - - -6.79 M -1.8 M -2.81 M - -13.2 M -8.9 M -4.76 M - -11 M -7.06 M - - - -2.13 M - - -5.97 M -3.87 M - - -3.5 M -2.33 M - - -1.87 M -1.53 M - - -1.66 M -1.32 M - - -2.49 M -1.53 M - - -2.85 M -1.79 M -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
-1.32 M -42.2 M -7.9 M